Christopher Scrase

7.4k total citations · 3 hit papers
38 papers, 3.3k citations indexed

About

Christopher Scrase is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Christopher Scrase has authored 38 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 18 papers in Radiation and 10 papers in Surgery. Recurrent topics in Christopher Scrase's work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (19 papers) and Advanced Radiotherapy Techniques (18 papers). Christopher Scrase is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (19 papers) and Advanced Radiotherapy Techniques (18 papers). Christopher Scrase collaborates with scholars based in United Kingdom, New Zealand and Germany. Christopher Scrase's co-authors include Emma Hall, David P. Dearnaley, Isabel Syndikus, Roger A’Hern, Mark Sydenham, Kevin J. Harrington, B. Yap, F. Adab, Robert Huddart and Christopher M. Nutting and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Christopher Scrase

38 papers receiving 3.2k citations

Hit Papers

Parotid-sparing intensity modulated versus conventional r... 2007 2026 2013 2019 2011 2007 2014 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
    2011 1.2k citations Christopher M. Nutting, James P. Morden et al. The Lancet Oncology profile →
  2. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
    2007 686 citations David P. Dearnaley, Matthew R. Sydes et al. The Lancet Oncology profile →
  3. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
    2014 344 citations David P. Dearnaley, Gordana Jovic et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Scrase United Kingdom 19 2.3k 1.6k 1.0k 817 671 38 3.3k
Abrahim Al‐Mamgani Netherlands 29 1.6k 0.7× 1.2k 0.8× 1.1k 1.1× 805 1.0× 695 1.0× 86 2.8k
Wilma D. Heemsbergen Netherlands 32 4.0k 1.8× 3.2k 2.0× 489 0.5× 708 0.9× 1.5k 2.2× 113 5.1k
Elizabeth Miles United Kingdom 22 1.2k 0.5× 1.2k 0.7× 1.2k 1.1× 724 0.9× 783 1.2× 65 2.4k
Piet Dirix Belgium 28 999 0.4× 474 0.3× 1.4k 1.3× 964 1.2× 1.3k 2.0× 81 3.2k
Gabriela Studer Switzerland 32 1.3k 0.6× 536 0.3× 1.2k 1.2× 822 1.0× 768 1.1× 118 2.9k
Jerry L. Barker United States 17 780 0.3× 816 0.5× 532 0.5× 402 0.5× 617 0.9× 36 1.8k
Riccardo Ragona Italy 28 1.3k 0.6× 1.0k 0.6× 367 0.4× 871 1.1× 647 1.0× 128 2.6k
Francesco Ricchetti Italy 27 1.4k 0.6× 1.4k 0.9× 476 0.5× 354 0.4× 911 1.4× 113 2.4k
Oren Cahlon United States 24 1.5k 0.6× 998 0.6× 261 0.3× 569 0.7× 536 0.8× 105 2.5k
R. de Crevoisier France 23 783 0.3× 531 0.3× 586 0.6× 626 0.8× 734 1.1× 91 1.9k

Countries citing papers authored by Christopher Scrase

Since Specialization
Citations

This map shows the geographic impact of Christopher Scrase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Scrase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Scrase more than expected).

Fields of papers citing papers by Christopher Scrase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Scrase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Scrase. The network helps show where Christopher Scrase may publish in the future.

Co-authorship network of co-authors of Christopher Scrase

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Scrase. A scholar is included among the top collaborators of Christopher Scrase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Scrase. Christopher Scrase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Syndikus, Isabel, Clare Griffin, L. Philipps, et al.. (2023). 10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016).. Journal of Clinical Oncology. 41(6_suppl). 304–304. 11 indexed citations
2.
Tree, Alison, Clare Griffin, Isabel Syndikus, et al.. (2022). Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial. International Journal of Radiation Oncology*Biology*Physics. 113(2). 305–315. 5 indexed citations
3.
Dearnaley, David P., Clare Griffin, Isabel Syndikus, et al.. (2020). Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial.. Journal of Clinical Oncology. 38(6_suppl). 325–325. 6 indexed citations
4.
Naismith, Olivia, Clare Griffin, Isabel Syndikus, et al.. (2019). Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity. Clinical Oncology. 31(9). 600–610. 3 indexed citations
5.
Murray, Julia, S. Gulliford, Clare Griffin, et al.. (2019). Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial. Clinical and Translational Radiation Oncology. 21. 77–84. 20 indexed citations
6.
Murray, Julia, Clare Griffin, S. Gulliford, et al.. (2019). A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer. Radiotherapy and Oncology. 142. 62–71. 29 indexed citations
7.
Staffurth, John, Joanne Haviland, Anna Wilkins, et al.. (2018). Impact of Prostate Cancer Hypofractionation on Patient Reported Outcomes: Baseline to 5 Years Change in the CHHIP Trial. International Journal of Radiation Oncology*Biology*Physics. 102(3). S1–S2. 6 indexed citations
8.
Dearnaley, David P., Clare Griffin, Rebecca Lewis, et al.. (2018). Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL). International Journal of Radiation Oncology*Biology*Physics. 103(3). 605–617. 43 indexed citations
9.
Jovic, Gordana, Claire Murphy, Cyril Fisher, et al.. (2018). Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial. European Urology. 73(6). 968–976. 15 indexed citations
10.
Staffurth, John, Olivia Naismith, S. Gulliford, et al.. (2015). Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 92(4). 874–883. 77 indexed citations
11.
Langley, Ruth E., Howard Kynaston, Abdulla Alhasso, et al.. (2015). A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol. European Urology. 69(6). 1016–1025. 21 indexed citations
12.
Dearnaley, David P., Gordana Jovic, Isabel Syndikus, et al.. (2014). Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. The Lancet Oncology. 15(4). 464–473. 344 indexed citations breakdown →
13.
Masterson, Liam, Maral J. Rouhani, Neil Donnelly, et al.. (2014). Squamous Cell Carcinoma of the Temporal Bone. Otology & Neurotology. 35(3). 501–508. 31 indexed citations
14.
Tam, Moses, et al.. (2012). Production of 3-D printer-generated radiotherapy shells using DICOM CT, MRI or 3-D surface laser scan – Acquired STL files: Preclinical feasibility studies. UEA Digital Repository (University of East Anglia). 1 indexed citations
15.
Nutting, Christopher M., James P. Morden, Kevin J. Harrington, et al.. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. The Lancet Oncology. 12(2). 127–136. 1202 indexed citations breakdown →
16.
Nutting, C., Roger A’Hern, Mark Sydenham, et al.. (2009). First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). Journal of Clinical Oncology. 27(18S). LBA6006–LBA6006. 9 indexed citations
17.
Poortmans, Philip, Alberto Bossi, M. Bosset, et al.. (2007). Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiotherapy and Oncology. 84(2). 121–127. 222 indexed citations
18.
Dearnaley, David P., Matthew R. Sydes, John D. Graham, et al.. (2007). Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. The Lancet Oncology. 8(6). 475–487. 686 indexed citations breakdown →
19.
Boehmer, Dirk, P. Maingon, Philip Poortmans, et al.. (2006). Guidelines for primary radiotherapy of patients with prostate cancer. Radiotherapy and Oncology. 79(3). 259–269. 111 indexed citations
20.
James, Hayley, Christopher Scrase, & Andrew Poynter. (2004). Practical experience with intensity-modulated radiotherapy. British Journal of Radiology. 77(913). 3–14. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abrahim Al‐Mamgani Breakdown of academic impact, for papers by Wilma D. Heemsbergen Breakdown of academic impact, for papers by Elizabeth Miles Breakdown of academic impact, for papers by Piet Dirix Breakdown of academic impact, for papers by Gabriela Studer Breakdown of academic impact, for papers by Jerry L. Barker Breakdown of academic impact, for papers by Riccardo Ragona Breakdown of academic impact, for papers by Francesco Ricchetti Breakdown of academic impact, for papers by Oren Cahlon Breakdown of academic impact, for papers by R. de Crevoisier
Rankless by CCL
2026